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General practice
Effectiveness of corticosteroid injections versus
physiotherapy for treatment of painful stiff shoulder in
primary care: randomised trial
D A W M van der Windt, B W Koes, W DevillØ, A J P Boeke, B A de Jong, L M Bouter
Abstract
Objective To compare the effectiveness of
corticosteroid injections with physiotherapy for the
treatment of painful stiff shoulder.
Design Randomised trial.
Setting 40 general practices.
Subjects 109 patients consulting general practitioners
for shoulder pain were enrolled in the trial.
Interventions Patients were randomly allocated to 6
weeks of treatment either with corticosteroid
injections (53) or physiotherapy (56).
Main outcome measures Outcome assessments were
carried out 3, 7, 13, 26, and 52 weeks after
randomisation; some of the assessments were done by
an observer blind to treatment allocation. Primary
outcome measures were the success of treatment as
measured by scores on scales measuring
improvement in the main complaint and pain, and
improvement in scores on a scale measuring shoulder
disability.
Results At 7 weeks 40 (77%) out of 52 patients
treated with injections were considered to be
treatment successes compared with 26 (46%) out of
56 treated with physiotherapy (difference between
groups 31%, 95% confidence interval 14% to 48%).
The difference in improvement favoured those treated
with corticosteroids in nearly all outcome measures;
these differences were statistically significant. At 26
and 52 weeks differences between the groups were
comparatively small. Adverse reactions were generally
mild. However, among women receiving treatment
with corticosteroids adverse reactions were more
troublesome: facial flushing was reported by 9 women
and irregular menstrual bleeding by 6, 2 of whom
were postmenopausal.
Conclusions The beneficial effects of corticosteroid
injections administered by general practitioners for
treatment of painful stiff shoulder are superior to
those of physiotherapy. The differences between the
intervention groups were mainly the result of the
comparatively faster relief of symptoms that occurred
in patients treated with injections. Adverse reactions
were generally mild but doctors should be aware of
the potential side effects of injections of
triamcinolone, particularly in women.
Introduction
Shoulder pain is a common complaint in primary care;
estimates of the annual incidence in general practice
vary from 6.6 to 25 cases per 1000 patients.1–3 Shoulder
conditions that are characterised by a painful
restriction of the passive range of motion, particularly
of lateral rotation and abduction, are usually referred
to as painful stiff shoulder or capsular syndrome.3 4
Despite the fact that in many cases symptoms persist5 6
few patients are referred to a specialist.2 5 In primary
care, diagnosis is usually based only on history and
physical examination.
Treatment often consists of physiotherapy or local
infiltration of a corticosteroid.3 Systematic reviews have
shown that the effectiveness of these interventions
remains questionable.7–9 Our objective was to compare
the effectiveness of corticosteroid injections with
physiotherapy on the treatment of painful stiff
shoulder in a primary care setting.
Subjects and methods
Subjects
Consecutive patients who consulted one of 60
participating general practitioners were considered for
participation. The main inclusion criteria were that
patients had a painful restriction of glenohumeral
mobility, were age 18 years or older, and gave informed
consent. Patients were excluded if they had bilateral
symptoms; if they had had treatment with corticosteroid
injections or physiotherapy during the preceding six
months; if they had contraindications to treatment; if
they had had surgery, dislocation, or fractures in the
shoulder area; if they had insulin›dependent diabetes
mellitus, systemic disorders of the musculoskeletal
system, or neurological disorders. Patients who met the
selection criteria were referred to the research centre by
their general practitioner. The study protocol was
approved by the Ethics Committee of the University
Hospital of the Vrije Universiteit Amsterdam.
At the research centre an independent observer,
who was a trained physiotherapist, confirmed that all
selection criteria had been met. The diagnosis of pain›
ful stiff shoulder (capsular syndrome) was made using
the diagnostic guidelines for shoulder complaints
issued by the Dutch College of General
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Practitioners3 4—that is, passive glenohumeral mobility
must be painful and limited, lateral rotation must be
relatively more restricted than abduction and medial
rotation, and there must be no clear signs (painful arc,
positive resistance tests, loss of power) that the
shoulder pain was caused by another condition. After
enrollment prognostic indicators and baseline values
of outcome measures were assessed.
Randomisation
Patients were randomly allocated six weeks of either
treatment with injections or physiotherapy (figure). The
use of permuted blocks of four patients guaranteed
nearly equal distribution of patients between the
interventions. The random sequence of the blocks was
generated using random number tables. Numbered,
opaque, sealed envelopes containing the treatment allo›
cation were prepared before the trial. After selection and
baseline assessment an administrative assistant opened
the next envelope in the appropriate stratum.
Interventions
Intra›articular injections of 40 mg triamcinolone
acetonide were given by the general practitioners using
the posterior route.10 Nearly all of the general
practitioners had attended training in this technique
before the study, although most had had previous
experience with the technique. No more than three
injections were given during the six weeks.
Physiotherapy consisted of 12 sessions of 30
minutes during which all patients received passive joint
mobilisation and exercise treatment. Ice, hot packs, or
electrotherapy could be used to reduce pain. Acupunc›
ture and high velocity thrust manipulations were not
allowed under the protocol. Ultrasound treatment was
not used because it was not considered to be effective
for this disorder. Treatment could be adjusted accord›
ing to the severity of symptoms. Physiotherapists and
general practitioners recorded details of treatment on
standardised forms which included spaces for docu›
menting deviations from protocol and adverse
reactions. Adverse reactions were also recorded by
patients on their own forms.
Patients were allowed to continue taking drugs for
pain if they had started before enrollment; drugs could
also be prescribed if pain was severe. All other
interventions were to be avoided during the study.
Outcome assessment
The outcome of the intervention was assessed at 3 and
7 weeks. Additional follow up assessments were sched›
uled for 13, 26, and 52 weeks. The assessments at 13
and 52 weeks were by postal questionnaire only but
contained all primary outcome measures.
Primary outcome measures
Patients were asked to score their improvement on a six
point Likert scale. For the analysis of success rates for
each treatment patients who rated themselves as having
made a complete recovery or as having much improve›
ment were counted as successes. Patients were asked to
score the pain associated with their main complaint and
the severity of their pain during the day and at night on
a 100 mm visual analog scale; the score of 100 indicates
very severe pain.11 Functional disability was evaluated
with the shoulder disability questionnaire, a 16 item
scale consisting of common situations that might cause
shoulder pain.12 13 Scores on the questionnaire range
from 0 to 100; 100 indicates severe disability.
Secondary outcome measures
After a standardised physical examination the inde›
pendent observer scored the overall clinical severity of
the disorder on a visual analog scale. Using the healthy
shoulder as a reference, the observer measured the
restriction of mobility during passive lateral rotation and
glenohumeral abduction with a digital inclinometer
(EDI›320, Cybex, Ronkonkoma, New York).14
Blinding
The independent observer did not know to which
intervention a patient had been allocated. To optimise
blinding the patient was instructed by the administra›
tive assistant not to reveal any information about their
treatment. In all patients the actual or potential
injection site was covered with gauze. Immediately after
each examination the observer was asked to guess to
which intervention the patient had been assigned.
Patients referred by general practitioners
(203)
Randomisation
(109)
Allocated to treatment with physiotherapy
(56)
Allocated to treatment with corticosteroid injections
(53)
Received physiotherapy as allocated
(46)
Received injections as allocated
(51)
Did not receive physiotherapy as allocated (10):
  Patients had additional injections (5)
  Patients recovered before beginning treatment (2)
  Patients had fewer than nine sessions
  due to absence (3)
Did not receive injections as allocated (2):
  Patient had additional physiotherapy (1)
  Patient refused injections (1)
Follow up:
  at 3 weeks (55)
  at 7 weeks (56)
  at 13 weeks (55)
  at 26 weeks (54)
  at 52 weeks (54)
Follow up:
  at 3 weeks (52)
  at 7 weeks (52)
  at 13 weeks (52)
  at 26 weeks (51)
  at 52 weeks (49)
Withdrawn from study (2):
  at 26 weeks due to myocardial infarction (1)
  at 52 weeks lost to follow up (1)
Withdrawn from study (4):
  at 3 weeks patient refused injections (1)
  at 26 weeks patient diagnosed with
      Alzheimer's disease (1)
  at 52 weeks lost to follow up (2)
Completed trial
(54)
Completed trial
(49)
Not randomised
(94)
Diagnosis not confirmed (73)
Patients did not give consent (6)
Patients had insulin-dependent diabetes mellitus (2)
Both shoulders involved (4)
Spontaneous recovery (5)
Patients had had physiotherapy or corticosteroid
  injection (4)
Randomisation of patients in and withdrawal of patients from the trial
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Statistical analysis
The changes in scores of symptoms over time were cal›
culated for each patient by subtracting the results at
baseline from those at follow up. The differences in the
changes in symptom scores between the two groups
were computed with 95% confidence intervals. The
principal analysis was performed on an intention to
treat basis. In an alternative analysis all patients who
had not been treated according to protocol during the
intervention period were excluded; these were cases of
non›compliance with treatment and violation of
protocols. Statistical analysis of the differences in
improvement between the groups over time was done
using a multivariate analysis of variance (repeated
measurements design); this analysis included the
results of outcome assessments at each follow up (at
baseline, 3, 7, 13, 26, and 52 weeks).15
Calculations of sample size were based on the ability
to detect a clinically important difference in success rate
of 25% between the two groups. We assumed a success
rate of 40% in the group having the least successful
treatment and thus estimated the target sample size at
60 patients in each group (two tailed, á = 0.05, â = 0.20).
Results
Patient flow and follow up
A total of 109 out of 203 patients referred by their gen›
eral practitioners were enrolled in the trial. Most of the
exclusions (73/94) were made because the independ›
ent observer could not confirm capsular syndrome as
the main cause of shoulder pain. Other probable
causes of pain were diagnosed as rotator cuff tendinitis,
subacromial bursitis, and dysfunction of the cervical
spine. Twenty one patients were excluded for other
reasons (figure).
One patient withdrew from the study immediately
after randomisation, refusing to have any injections. A
total of six patients (5.5%) withdrew from the study,
four of whom reported complete recovery before with›
drawal. All patients who withdrew from the study were
included in the statistical analysis until withdrawal.
Characteristics of patients
Fifty three patients were allocated to treatment with
injections and 56 patients to physiotherapy. Despite
randomisation there were some differences between
the intervention groups in regard to sex, the onset of
pain, involvement of the dominant side, concomitant
neck pain, previous episodes of shoulder pain, baseline
severity of the main complaint, and rating of the pain
at night (table 1).
Interventions
Twenty five patients (48%) allocated to receive
injections had three injections. The mean number of
injections was 2.2 (SD 0.8). All patients allocated to
physiotherapy received passive joint mobilisation and
exercise treatment. Additional electrotherapy was used
in 41 patients and ice or hot packs in 33.
At baseline, the use of pain medication was evenly
distributed between the two groups; 15 patients in each
group used paracetamol (acetaminophen) or non›
steroidal anti›inflammatory drugs. The number of
patients needing additional treatment after six weeks
and the types of treatment received are shown in table
2. Additional treatment was given more often to
patients allocated to physiotherapy (75% v 42%).
The observer correctly guessed the allocated treat›
ment for 65 (60%) out of 108 patients after 7 weeks and
for 51 (48%) out of 105 after 26 weeks. The frequency
of correct guesses was similar in both groups (30/52
(58%) for patients having injections and 35/56 (63%)
for those having physiotherapy at 7 weeks).
Outcome
The mean improvement in outcome measures at each
point of follow up is shown in table 3. Using the inten›
tion to treat analysis we found a statistically significant
Table 1 Baseline characteristics of patients with painful stiff shoulder by treatment
received. Values are numbers (percentages) unless indicated otherwise
Patients treated with
corticosteroid injection
(n=53)
Patients treated
with physiotherapy
(n=56)
Mean (SD) age (years) 57.3 (10.2) 60.2 (10.7)
Women 25 (47) 33 (59)
Concomitant neck pain 24 (45) 32 (57)
Previous episodes of shoulder pain 23 (43) 17 (30)
Duration of current episode (months):
<1 7 (13) 6 (11)
>1›3 21 (40) 26 (46)
>3›6 13 (24) 9 (16)
>6›12 8 (15) 9 (16)
>12 4 (8) 6 (11)
Acute onset 9 (17) 15 (27)
Precipitating cause:
Overuse or strain 7 (13) 7 (13)
Minor injury 8 (15) 7 (13)
Unknown 35 (66) 34 (61)
Dominant shoulder affected 18 (34) 25 (45)
Course of symptoms preceding enrollment:
Improved 4 (8) 7 (13)
Stable 34 (64) 35 (65)
Deteriorated 15 (28) 12 (22)
Median (interquartile range) rating of severity as measured on visual analog scale*:
Associated with main complaint 86 (74 to 93) 78 (62 to 87)
Of pain during the day 49 (28 to 66) 48 (31 to 65)
Of pain at night 52 (11 to 75) 43 (16 to 78)
According to observer 56 (30 to 65) 53 (37 to 60)
Median (interquartile range) rating of shoulder disability† 69 (56 to 81) 69 (56 to 85)
Median (interquartile range) degree of restriction of range of motion‡:
Lateral rotation 22 (8 to 31) 19 (8 to 34)
Glenohumeral abduction 40 (25 to 50) 35 (22 to 48)
*Range of scores is 0›100; 100 indicates very severe pain.
†Range of scores on shoulder disability questionnaire is 0›100; 100 indicates severe disability.11 12
‡Restriction of range of motion as compared to healthy shoulder; measured by the independent observer.
Table 2 Number (percentage) of patients with painful stiff shoulder needing treatment
for residual pain or disability at seven week follow up (treatment no longer restricted to
interventions as described by protocol)
Additional treatment
Patients
All (n=108)*
Treated with
corticosteroid
injection (n=52)*
Treated with
physiotherapy (n=56)
None 44 (41) 30 (58) 14 (25)
Paracetamol or non›steroidal
anti›inflammatory drugs
6 (5) 2 (4) 4 (7)
Corticosteroid injection 16 (15) 6 (11) 10 (18)
Physiotherapy 27 (25) 8 (15) 19 (34)
Corticosteroid injections and
physiotherapy
13 (12) 5 (10) 8 (14)
Arthroscopic surgery 2 (2) 1 (2) 1 (2)
*One patient withdrew from the study after three weeks so no information on additional treatment was
available.
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difference between the groups which favoured treat›
ment with corticosteroid injections. In a multivariate
analysis differences in prognosis at baseline had little
influence on the outcome of the study (data not shown).
At 7 weeks 40 (77%) out of 52 patients treated with
injections were considered to be treatment successes
compared with 26 (46%) out of 56 treated with physio›
therapy (difference between groups 31%, 95% confi›
dence interval 14% to 48%). The difference in
improvement was in the same direction for all
outcome measures; these differences were statistically
significant (multivariate analysis of variance) for most
outcome measures but not for restriction of abduction
and severity of the main complaint. The change in
scores for the main complaint had a non›gaussian dis›
tribution. Non›parametric testing (Mann›Whitney U
test) indicated that there was a significantly greater
improvement in the main complaint among those
treated with corticosteroids at 3, 7, 13, and 52 weeks.
Table 3 shows that the differences between the groups
were mainly due to the comparatively fast relief of
symptoms occurring among those receiving cortico›
steroids. At assessment at 26 and 52 weeks there were
comparatively small differences between the groups.
An alternative analysis was conducted which
excluded 12 patients who were not treated according
to protocol. For all outcome measures the results were
similar to those in the intention to treat analysis. At 7
weeks treatment was considered to be successful in 39
(77%) out of 51 patients receiving injections and in 22
(48%) out of 46 for those treated with physiotherapy.
Adverse reactions
Mild adverse reactions, mainly increased pain after treat›
ment, were reported by more than 50% (62/108) of all
patients (table 4). Few adverse reactions occurred after
physiotherapy. Adverse reactions to corticosteroids were
particularly frequent in women; facial flushing was
reported by nine and irregular menstrual bleeding by
six women, two of whom were postmenopausal.
Discussion
This paper describes a randomised trial in a primary
care setting that compared two common interventions,
corticosteroid injections and physiotherapy, for treat›
ment of painful stiff shoulder. The analysis done on an
intention to treat basis and an alternative analysis that
excluded patients whose treatment deviated from the
protocol showed that corticosteroid injections were
superior to physiotherapy in terms of the success of
treatment; improvement in degree of lateral rotation;
improvement in clinical severity; and in relief of the
main complaint, pain, and disability. We decided
against performing an analysis of the long term results
by treatment actually received as this would have
produced a biased outcome. The reasons for conclud›
ing or modifying treatment were, after all, strongly
related to the results of the allocated intervention.16
Four earlier trials compared the effectiveness of
corticosteroid injections with physiotherapy for shoul›
der pain.17–20 Three trials with relatively small study
populations (fewer than 25 patients per intervention
group) were unable to show significant differences
between the treatments. These studies used a single
injection17 19 or a different type of corticosteroid.18 19
Table 3 Mean (SD) improvement in outcome measures in patients with painful stiff
shoulder and differences between groups by treatment at different points in follow up
Patients treated
with
corticosteroid
injection*
Patients treated
with
physiotherapy*
Mean (95% CI)
difference between
groups P value
Improvement in rating of severity†
Associated with main complaint:
3 weeks 32 (26) 17 (21) 15 (6 to 24)
(0.071)‡
7 weeks 58 (28) 32 (29) 26 (15 to 37)
13 weeks 66 (28) 47 (33) 19 (7 to 31)
26 weeks 63 (31) 54 (33) 9 (−3 to 22)
52 weeks 70 (24) 59 (30) 11 (1 to 23)
Of pain during the day:
3 weeks 22 (20) 10 (15) 12 (5 to 18)
< 0.001
7 weeks 35 (20) 23 (24) 12 (4 to 21)
13 weeks 36 (26) 27 (31) 9 (−3 to 20)
26 weeks 32 (25) 32 (28) 0 (−10 to 10)
52 weeks 38 (23) 35 (26) 3 (−7 to 13)
Of pain at night:
3 weeks 21 (26) 9 (23) 12 (2 to 21)
0.015
7 weeks 36 (28) 22 (30) 14 (3 to 25)
13 weeks 37 (33) 28 (36) 9 (−4 to 23)
26 weeks 34 (36) 33 (41) 1 (−13 to 17)
52 weeks 37 (33) 35 (39) 2 (−12 to 16)
As rated by observer:
3 weeks 13 (17) 0 (18) 13 (6 to 20)
<0.0017 weeks 24 (20) 9 (20) 15 (7 to 22)
26 weeks 29 (24) 27 (27) 2 (−9 to 11)
Improvement in rating of shoulder disability§
3 weeks 19 (27) 6 (22) 13 (4 to 23)
0.024
7 weeks 39 (27) 14 (27) 25 (14 to 35)
13 weeks 38 (31) 28 (32) 10 (−2 to 22)
26 weeks 45 (30) 33 (34) 12 (0 to 25)
52 weeks 42 (33) 38 (34) 4 (−10 to 17)
Improvement in degree of restriction of range of motion
External rotation:
3 weeks 6 (14) –3 (12) 9 (3 to 14)
0.0027 weeks 13 (16) –2 (14) 15 (9 to 20)
26 weeks 16 (18) 7 (21) 9 (1 to 16)
Abduction:
3 weeks 2 (12) –3 (13) 5 (0 to 9)
0.0657 weeks 4 (11) –1 (14) 5 (0 to 10)
26 weeks 9 (12) 7 (17) 2 (−3 to 8)
*At 3 and 13 weeks there is one missing value in each group. At 7 weeks there is one missing value in the
injection group. At 26 weeks there are one missing value in the injection group and two in the
physiotherapy group. At 52 weeks there are four missing values in the injection group and one in the
physiotherapy group.
†Pain as rated on visual analog scale in which scores range from 0›100; 100 indicates very severe pain.
‡The change in scores for this outcome measure show a non›gaussian distribution. Non›parametric testing
results in statistically significant differences at 3, 7, 13, and 52 weeks
§As rated on shoulder disability questionnaire in which scores range from 0›100; 100 indicates severe
disability.11 12
Table 4 Frequency of adverse reactions to treatment for painful stiff shoulder. Values
are number of occurrences unless indicated otherwise
Patients treated with injection
(n=57)*
Patients treated with
physiotherapy (n=57)†
No of patients having any adverse reaction 30 (53%) 32 (56%)
Pain after treatment:
Lasting <1 day 9 17
Lasting >2 days 16 13
Facial flushing 9 1
Irregular menstrual bleeding 6‡ 0
Fever reported by patient 4 1
Skin irritation 1 2
Other reaction 6§ 4¶
*Includes 52 patients treated according to protocol and 5 patients treated with both interventions.
†Includes 56 patients treated according to protocol and one patient treated with both interventions.
‡Two of these women were postmenopausal.
§Reactions included sweating, fatigue, dry mouth, dizziness, and headache.
¶Reactions included slight swelling, tingling, and radiating pain.
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Only one trial was conducted in a primary care setting
and this trial reported significant differences between
the treatments.20 In that study treatment was considered
successful after five weeks for 35 (75%) out of 47 patients
treated with injections and for seven (20%) out of 35
treated with physiotherapy. Corticosteroid treatment
consisted of multiple injections. Passive mobilisation was
not permitted for patients allocated to physiotherapy, a
practice that is not compatible with everyday practice. To
enhance the external validity of our trial and to facilitate
implementation of the findings in clinical practice we
tried to ensure that the interventions used resembled
those carried out in primary care.
In this study injections were administered by
general practitioners. Inaccurate placement of intra›
articular injections is reported to occur often, even
among trained rheumatologists.21 22 Recent studies
report a better response to treatment after accurately
placed injections.22 23 Despite the inevitable uncertainty
about placement in our study, many of our patients had
a good response to the corticosteroid injections
administered by their general practitioner.
Adverse reactions were generally mild but were
sometimes troublesome, particularly in women receiv›
ing corticosteroid injections. Surprisingly, published
reports of irregular menstrual bleeding after cortico›
steroid injection are scarce. One letter that we
identified described this side effect as a frequent occur›
rence, especially in women not taking oral contracep›
tives.24 These observations should be investigated
further. Doctors and patients should be aware of the
possibility of irregular menstrual bleeding after
corticosteroid injection so that women are not
needlessly made anxious or subjected to diagnostic
procedures; however, women and their doctors should
be aware that postmenopausal bleeding may be a sign
of cancer of the endometrium or cervix.
This randomised trial showed that corticosteroid
injections administered by general practitioners for
treatment of painful stiff shoulder are superior to
physiotherapy. Differences between the intervention
groups were mainly due to the comparatively quick
relief of symptoms occurring in patients treated with
injections. Injections may be preferable to physio›
therapy in the initial treatment of painful stiff shoulder.
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Key messages
+ There is little evidence supporting the effectiveness of either
corticosteroid injections or physiotherapy in painful stiff shoulder
+ Few studies of the effectiveness of treatments for shoulder pain
have been done in a primary care setting even though most
patients with shoulder pain are treated there
+ This randomised trial shows that patients treated with corticosteroid
injections are significantly more likely to improve on measures of
pain and disability than patients treated with physiotherapy
+ The differences between those who received injections and those
treated with physiotherapy result mainly from comparatively fast
relief of symptoms that occurs after injections
+ Doctors and patients should be aware of mild, but sometimes
troublesome, adverse reactions to corticosteroids that may occur
General practice
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